Compare Recursion Pharmaceuticals Inc (RXRX) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Direxion Daily TSLA Bull 2X Shares trades at $11.25. Which is the better fit depends on your goals.
| RXRX | TSLL | |
|---|---|---|
Market Cap | $1.53B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $6.79 | $23.03 |
52-Week Low | $2.84 | $10.29 |
Enterprise Value | $946.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
